Novo NordiskSee all their emails

Novo Nordisk STEP Young phase 3 data: 40.4% of children living with obesity achieved a BMI below the obesity threshold with semaglutide and lifestyle modification

A real announcement email from Novo Nordisk. Captured September 7, 2026.

Make this email yours

Migma AI designs one like it with your logo, colors, and images.

Novo Nordisk STEP Young phase 3 data: 40.4% of children living with obesity achieved a BMI below the obesity threshold with semaglutide and lifestyle modification email from Novo Nordisk screenshot

Captured Announcement

Novo Nordisk press release announcing phase 3 trial results for semaglutide in treating childhood obesity.

Logo at top left, followed by headline, data highlights bullet points, extensive text sections, a structured data table, and contact details at the bottom.

Original email and brand assets belong to their respective owners. Design notes describe the creative, not campaign results.